Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 16:57:101860.
doi: 10.1016/j.eclinm.2023.101860. eCollection 2023 Mar.

Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis

Saifur Rahman Chowdhury  1   2 , Dipak Chandra Das  1 , Tachlima Chowdhury Sunna  1 , Joseph Beyene  2 , Ahmed Hossain  3   4
Affiliations

Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis

Saifur Rahman Chowdhury et al. EClinicalMedicine. .

Abstract

Background: Knowing the prevalence of multimorbidity among adults across continents is a crucial piece of information for achieving Sustainable Development Goal 3.4, which calls for reducing premature death due to non-communicable diseases. A high prevalence of multimorbidity indicates high mortality and increased healthcare utilization. We aimed to understand the prevalence of multimorbidity across WHO geographic regions among adults.

Methods: We performed a systematic review and meta-analysis of surveys designed to estimate the prevalence of multimorbidity among adults in community settings. We searched PubMed, ScienceDirect, Embase and Google Scholar databases for studies published between January 1, 2000, and December 31, 2021. The random-effects model estimated the pooled proportion of multimorbidity in adults. Heterogeneity was quantified using I2 statistics. We performed subgroup analyses and sensitivity analyses based on continents, age, gender, multimorbidity definition, study periods and sample size. The study protocol was registered with PROSPERO (CRD42020150945).

Findings: We analyzed data from 126 peer-reviewed studies that included nearly 15.4 million people (32.1% were male) with a weighted mean age of 56.94 years (standard deviation of 10.84 years) from 54 countries around the world. The overall global prevalence of multimorbidity was 37.2% (95% CI = 34.9-39.4%). South America (45.7%, 95% CI = 39.0-52.5) had the highest prevalence of multimorbidity, followed by North America (43.1%, 95% CI = 32.3-53.8%), Europe (39.2%, 95% CI = 33.2-45.2%), and Asia (35%, 95% CI = 31.4-38.5%). The subgroup study highlights that multimorbidity is more prevalent in females (39.4%, 95% CI = 36.4-42.4%) than males (32.8%, 95% CI = 30.0-35.6%). More than half of the adult population worldwide above 60 years of age had multimorbid conditions (51.0%, 95% CI = 44.1-58.0%). Multimorbidity has become increasingly prevalent in the last two decades, while the prevalence appears to have stayed stable in the recent decade among adults globally.

Interpretation: The multimorbidity patterns by geographic regions, time, age, and gender suggest noticeable demographic and regional differences in the burden of multimorbidity. According to insights about prevalence among adults, priority is required for effective and integrative interventions for older adults from South America, Europe, and North America. A high prevalence of multimorbidity among adults from South America suggests immediate interventions are needed to reduce the burden of morbidity. Furthermore, the high prevalence trend in the last two decades indicates that the global burden of multimorbidity continues at the same pace. The low prevalence in Africa suggests that there may be many undiagnosed chronic illness patients in Africa.

Funding: None.

Keywords: Chronic disease; Global prevalence; Meta-analysis; Multimorbidity; Systematic review.

PubMed Disclaimer

Conflict of interest statement

All other authors declare no competing interests.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram for study selection.
Fig. 2
Fig. 2
Forest Plot of the Overall Prevalence of multimorbidity in community settings.
Fig. 3
Fig. 3
Regional differences of pooled prevalence of multimorbidity by gender.
Fig. 4
Fig. 4
Pooled prevalence of multimorbidity by year.
See this image and copyright information in PMC

References

    1. Moffat K., Mercer S.W. Challenges of managing people with multimorbidity in today's healthcare systems. BMC Fam Pract. 2015;16:129. doi: 10.1186/s12875-015-0344-4. - DOI - PMC - PubMed
    1. GBD 2015 Mortality and Causes of Death Collaborators Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–1544. doi: 10.1016/S0140-6736(16)31012-1. Erratum in: Lancet. 2017 Jan 7;389(10064):e1. - DOI - PMC - PubMed
    1. Hussain M.A., Huxley R.R., Al Mamun A. Multimorbidity prevalence and pattern in Indonesian adults: an exploratory study using national survey data. BMJ Open. 2015;5(12) doi: 10.1136/bmjopen-2015-009810. - DOI - PMC - PubMed
    1. Ryan A., Wallace E., O'Hara P., Smith S.M. Multimorbidity and functional decline in community-dwelling adults: a systematic review. Health Qual Life Outcomes. 2015;13:168. doi: 10.1186/s12955-015-0355-9. - DOI - PMC - PubMed
    1. Zhang X., Padhi A., Wei T., et al. Community prevalence and dyad disease pattern of multimorbidity in China and India: a systematic review. BMJ Glob Health. 2022 Sep;7(9) doi: 10.1136/bmjgh-2022-008880. - DOI - PMC - PubMed

LinkOut - more resources